Patient Capital Sees Long-Term Potential in Chime
The investment strategy highlighted Chime as a top-ten holding and said its low-cost banking model could support long-term growth.
Makkler Newsroom · Oct 12, 06:51 PM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $42.00 (+25.2%)
Prices may be delayed and are for informational purposes only - not investment advice.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.